Youku Tudou Inc (ADR) (NYSE:YOKU) announced its unaudited financial results for fourth quarter and fiscal year 2013. Net revenues were RMB901.3 million (US$148.9 million) in the fourth quarter of 2013, a 42% increase from the corresponding period in 2012 and exceeding the high end of the net revenues guidance previously announced by the Company.Youku Tudou Inc (ADR) (NYSE:YOKU) shares after opening at $29.32 moved to $31.08 on last trade day and at the end of the day closed at $30.74. Company price to sales ratio in past twelve months was calculated as 11.39 and price to cash ratio as 9.79. Youku Tudou Inc (ADR) (NYSE:YOKU) showed a negative weekly performance of -0.97%.
Questcor Pharmaceuticals (NASDAQ:QCOR) Insider David Young sold 6,000 shares of the company’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $62.28, for a total transaction of $373,680.00. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shares advanced 5.33% in last trading session and ended the day on $65.04. QCOR return on equity ratio is recorded as 105.30% and its return on assets is 57.80%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) yearly performance is 103.76%.
Braskem SA (ADR) (NYSE:BAK) has signed with the Brazilian Innovation Agency (FINEP) an agreement for conducting research into plastic packaging using nanotechnology at the company’s Technology Center located at the Triunfo Petrochemical Complex in the state of Rio Grande do Sul. Braskem SA (ADR) (NYSE:BAK) shares moved up 5.24% in last trading session and was closed at $13.65 while trading in range of $12.91 – $13.71 – Braskem SA (ADR) (NYSE:BAK) year to date (YTD) performance is -23.53%.
Needham & Company reiterated their buy rating on shares of Intercept Pharmaceuticals (NASDAQ:ICPT) in a research note released on Monday morning, Analyst Ratings Network reports. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) weekly performance is -0.73%. On last trading day company shares ended up $434.96. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) distance from 50-day simple moving average (SMA50) is 29.34%. Analysts mean target price for the company is $525.86.
Leave a Reply